News

March 7, 2008 – An individual’s physical health, psychological stress, social support and own sense of well-being, are all factors that can play a significant role in the likelihood of surviving...

February 5, 2008 - Doctors completed the first implant of Boston Scientific’s COGNIS cardiac resynchronization therapy defibrillator (CRT-D), which reportedly represents an entirely new platform...

March 3, 2008 – The FDA granted 510(k) clearance for the AIGISRX CRMD Anti-Bacterial Envelope by Tyrxpharma, a cardiac rhythm medical device intended to immobilize and reduce bacterial infection...

February 29, 2008 - Physicians began performing the first European implants of the COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and the TELIGEN implantable cardioverter...

February 27, 2008 - Boston Scientific Corp. said the FDA approved three products in its Cardiac Rhythm Management business, including the CONFIENT implantable cardioverter defibrillator (ICD), the...

February 4, 2008 – Fluke Biomedical unveiled today new defibrillator and pacemaker analyzer technologies, the Impulse 6000D Defibrillator Analyzer and the Impulse 7000DP Defibrillator/Pacer...

January 22, 2008 - Boston Scientific Corp. today announced CE Mark approval for its COGNIS cardiac resynchronization therapy defibrillator (CRT-D) and TELIGEN implantable cardioverter...

January 22, 2008 - The International Board of Heart Rhythm Examiners (IBHRE) issued the first standardized cardiac pacing exam for Japanese allied professionals, which marks the first time the...

January 8, 2007 - Cardiac Science Corp. expects 2007 fourth quarter revenue to total approximately $50 million, representing growth of approximately 28 percent compared with the fourth quarter of...

December 29, 2007 - Boston Scientific Corp. received CE Mark approval for its LIVIAN cardiac resynchronization therapy defibrillator (CRT-D), which treats heart failure and is designed to help...

December 26, 2007 - Medtronic Inc. announced that it has entered into an agreement to settle lawsuits relating to its Marquis line of implanted cardiac defibrillators that were the subject of a...

December 4, 2007 - ELA Medical Inc. intiated U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications), which will evaluate therapies and...

November 13, 2007- There is significant underutilization of many guideline-indicated life-saving medical and device therapies for heart failure (HF) patients, according to the Registry to Improve...

November 7, 2007 - The application of clinical practice modifications combined with advanced electronic technologies can improve the care of patients at risk for sudden cardiac arrest (SCA),...

October 16, 2007 – Medtronic Inc. said in a statement that it has voluntarily suspended worldwide distribution of the Sprint Fidelis family of defibrillation leads because of the potential for...

October 16, 2007 — In response to Medtronic’s decision to voluntarily suspend its Sprint Fidelis defibrillation leads, the Heart Rhythm Society (HRS) made a statement to underscore the importance...

October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status...

September 18, 2007 - St. Jude Medical Inc. announced FDA approval of its first radiofrequency (RF) wireless devices to treat patients with heart failure and with potentially lethal heart...